Eli Lilly profits more than double as weight-loss drug sales soar
First-quarter sales of medication Zepbound increased 80 per cent to $4.2bn
Eli Lilly profit more than doubles
- Bank signals interest rates could rise as Iran war to push up cost of living The Standard —
- Bank of England holds interest rates at 3.75% but hints at future hikes The Argus —
- Bailey: BOE Sees Inflation Little Over 3.5% by Year End Bloomberg —
- What the latest interest rates vote means for your mortgage, savings and bills The Independent —
- Lilly projects 2026 revenue of $82B-$85B and non-GAAP EPS of $35.50-$37 as Foundayo launch begins Seeking Alpha —